The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s pentavalent market report forecasts the pentavalent market size to grow to $2.98 Billion by 2027, with a CAGR (compound annual growth rate) of 4%.

Learn More On The Pentavalent Market Report 2023 – https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Pentavalent Market Size Forecast
The global pentavalent market is expected to grow from $2.43 billion in 2022 to $2.55 billion in 2023 at a compound annual growth rate (CAGR) of 5.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global pentavalent market size is expected to reach $2.98 billion in 2027 at a CAGR of 4%.

Asia-Pacific held the largest pentavalent market share.

Key Pentavalent Market Driver ­– Rise In The Prevalence Of Diphtheria
For example, an unusually high number of reported cases of diphtheria were recorded through the International Health Regulations (IHR) reporting process in 2022, according to the World Health Organisation, a Switzerland-based specialised agency of the United Nations, primarily in the months of June and August 2022. Seven countries have reported 144 cases of diphtheria, many of which were among asylum seekers. Among 144 patients, 97 (69%) were clinically compatible, 44 (31%) were confirmed to be toxigenic diphtheria cases by laboratory testing, and 3 (2%) were suspected cases. As a result, the increased prevalence of diphtheria is propelling the pentavalent market forward.

Request for A Sample Of The Global Pentavalent Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9104&type=smp

Key Pentavalent Market Trend – Product Innovation
To increase their market position, major businesses in the pentavalent industry are introducing revolutionary products. For example, in December 2022, Pfizer, a US-based pharmaceutical company active in the pentavalent vaccines market, received approval from The US Food and Drug Administration, a US-based federal agency of the Department of Health and Human Services, for Pfizer’s Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents, indicated for the prevention of meningococcal disease in individuals aged 10 to 25. The MenABCWY vaccination is unique in that it combines the components of two vaccines into one, thereby protecting against the meningococcal serogroups that cause the majority of invasive meningococcal illnesses.

Pentavalent Market Segment
1) By Type: Sodium Stibogluconate, Meglumine Antimoniate
2) By Formulation Type: Lyophilized, Liquid
3) By Application: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Pentavalent Market Major Players and Strategies
Major players in the pentavalent market are Sanofi, GlaxoSmithKline PLC., Bristol-Myers Squibb Company, Maiden Pharmaceuticals Limited, Shandong Xinhua Pharmaceutical Co.,Ltd., Albert David Limited, Serum Institute of India Pvt. Ltd., Panacea Drugs Pvt. Ltd., Shantha Biotechnics Limited, Biological E. Ltd., Novartis AG, Crucell, Pfizer Inc., Fierce Pharma, and Sinovac Biotech Ltd.

Ardian, a private equity investment firm located in France, paid an undisclosed sum for Biofarma Group in January 2022. Ardian’s acquisition would allow for further market consolidation and worldwide expansion. The Biofarma Group is an Italian company that specialises in pentavalent vaccines.

The Pentavalent Global Market Report 2023 covers regional data on pentavalent market size, pentavalent market trends and drivers, opportunities, strategies, and pentavalent market competitor analysis. The countries covered in the pentavalent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

A pentavalent vaccine protects a youngster from potentially fatal infections. This vaccination protects newborns and young children against rotavirus illness. Infection with rotavirus can cause fever, vomiting, and diarrhoea.

View More Reports Related To The Pentavalent Market –
Adult Vaccines Global Market Report 2023
Pediatric Vaccine Global Market Report 2023
Nanomaterials Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: